118 related articles for article (PubMed ID: 27797280)
1. North American ginseng (Panax quinquefolius) suppresses β-adrenergic-dependent signalling, hypertrophy, and cardiac dysfunction.
Tang X; Gan XT; Rajapurohitam V; Huang CX; Xue J; Lui EM; Karmazyn M
Can J Physiol Pharmacol; 2016 Dec; 94(12):1325-1335. PubMed ID: 27797280
[TBL] [Abstract][Full Text] [Related]
2. Ginseng reverses established cardiomyocyte hypertrophy and postmyocardial infarction-induced hypertrophy and heart failure.
Moey M; Gan XT; Huang CX; Rajapurohitam V; Martínez-Abundis E; Lui EM; Karmazyn M
Circ Heart Fail; 2012 Jul; 5(4):504-14. PubMed ID: 22576957
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of angiotensin II-induced hypertrophy and cardiac dysfunction by North American ginseng (
Tang X; Gan XT; Jong CJ; Rajapurohitam V; Karmazyn M
Can J Physiol Pharmacol; 2021 May; 99(5):512-521. PubMed ID: 33091308
[TBL] [Abstract][Full Text] [Related]
4. Ginseng (Panax quinquefolius) attenuates leptin-induced cardiac hypertrophy through inhibition of p115Rho guanine nucleotide exchange factor-RhoA/Rho-associated, coiled-coil containing protein kinase-dependent mitogen-activated protein kinase pathway activation.
Moey M; Rajapurohitam V; Zeidan A; Karmazyn M
J Pharmacol Exp Ther; 2011 Dec; 339(3):746-56. PubMed ID: 21875949
[TBL] [Abstract][Full Text] [Related]
5. Ginseng inhibits cardiomyocyte hypertrophy and heart failure via NHE-1 inhibition and attenuation of calcineurin activation.
Guo J; Gan XT; Haist JV; Rajapurohitam V; Zeidan A; Faruq NS; Karmazyn M
Circ Heart Fail; 2011 Jan; 4(1):79-88. PubMed ID: 20971938
[TBL] [Abstract][Full Text] [Related]
6. β-Adrenergic receptor stimulation causes cardiac hypertrophy via a Gβγ/Erk-dependent pathway.
Vidal M; Wieland T; Lohse MJ; Lorenz K
Cardiovasc Res; 2012 Nov; 96(2):255-64. PubMed ID: 22843704
[TBL] [Abstract][Full Text] [Related]
7. Endocytosis machinery is required for beta1-adrenergic receptor-induced hypertrophy in neonatal rat cardiac myocytes.
Morisco C; Marrone C; Galeotti J; Shao D; Vatner DE; Vatner SF; Sadoshima J
Cardiovasc Res; 2008 Apr; 78(1):36-44. PubMed ID: 18194989
[TBL] [Abstract][Full Text] [Related]
8. Phosphoinositide 3-kinase gamma-deficient mice are protected from isoproterenol-induced heart failure.
Oudit GY; Crackower MA; Eriksson U; Sarao R; Kozieradzki I; Sasaki T; Irie-Sasaki J; Gidrewicz D; Rybin VO; Wada T; Steinberg SF; Backx PH; Penninger JM
Circulation; 2003 Oct; 108(17):2147-52. PubMed ID: 12963636
[TBL] [Abstract][Full Text] [Related]
9. Exchange protein directly activated by cAMP mediates slow delayed-rectifier current remodeling by sustained β-adrenergic activation in guinea pig hearts.
Aflaki M; Qi XY; Xiao L; Ordog B; Tadevosyan A; Luo X; Maguy A; Shi Y; Tardif JC; Nattel S
Circ Res; 2014 Mar; 114(6):993-1003. PubMed ID: 24508724
[TBL] [Abstract][Full Text] [Related]
10. Regression of isoproterenol-induced cardiac hypertrophy by Na+/H+ exchanger inhibition.
Ennis IL; Escudero EM; Console GM; Camihort G; Dumm CG; Seidler RW; Camilión de Hurtado MC; Cingolani HE
Hypertension; 2003 Jun; 41(6):1324-9. PubMed ID: 12732584
[TBL] [Abstract][Full Text] [Related]
11. Apocynin prevents isoproterenol-induced cardiac hypertrophy in rat.
Saleem N; Prasad A; Goswami SK
Mol Cell Biochem; 2018 Aug; 445(1-2):79-88. PubMed ID: 29256115
[TBL] [Abstract][Full Text] [Related]
12. Small heat-shock protein Hsp20 attenuates beta-agonist-mediated cardiac remodeling through apoptosis signal-regulating kinase 1.
Fan GC; Yuan Q; Song G; Wang Y; Chen G; Qian J; Zhou X; Lee YJ; Ashraf M; Kranias EG
Circ Res; 2006 Nov; 99(11):1233-42. PubMed ID: 17068291
[TBL] [Abstract][Full Text] [Related]
13. B-type natriuretic peptide attenuates cardiac hypertrophy via the transforming growth factor-ß1/smad7 pathway in vivo and in vitro.
He JG; Chen YL; Chen BL; Huang YY; Yao FJ; Chen SL; Dong YG
Clin Exp Pharmacol Physiol; 2010 Mar; 37(3):283-9. PubMed ID: 19719752
[TBL] [Abstract][Full Text] [Related]
14. Comparison of pharmacodynamics between carvedilol and metoprolol in rats with isoproterenol-induced cardiac hypertrophy: effects of carvedilol enantiomers.
Hanada K; Asari K; Saito M; Kawana J; Mita M; Ogata H
Eur J Pharmacol; 2008 Jul; 589(1-3):194-200. PubMed ID: 18534575
[TBL] [Abstract][Full Text] [Related]
15. Connective tissue growth factor/CCN2 attenuates β-adrenergic receptor responsiveness and cardiotoxicity by induction of G protein-coupled receptor kinase-5 in cardiomyocytes.
Gravning J; Ahmed MS; Qvigstad E; Krobert K; Edvardsen T; Moe IT; Hagelin EM; Sagave J; Valen G; Levy FO; Osnes JB; Skomedal T; Attramadal H
Mol Pharmacol; 2013 Sep; 84(3):372-83. PubMed ID: 23778361
[TBL] [Abstract][Full Text] [Related]
16. RGS2 inhibits beta-adrenergic receptor-induced cardiomyocyte hypertrophy.
Nunn C; Zou MX; Sobiesiak AJ; Roy AA; Kirshenbaum LA; Chidiac P
Cell Signal; 2010 Aug; 22(8):1231-9. PubMed ID: 20362664
[TBL] [Abstract][Full Text] [Related]
17. Involvement of the serotonin 5-HT2B receptor in cardiac hypertrophy linked to sympathetic stimulation: control of interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha cytokine production by ventricular fibroblasts.
Jaffré F; Callebert J; Sarre A; Etienne N; Nebigil CG; Launay JM; Maroteaux L; Monassier L
Circulation; 2004 Aug; 110(8):969-74. PubMed ID: 15302781
[TBL] [Abstract][Full Text] [Related]
18. Isoproterenol induced hypertrophy and associated signaling pathways are modulated by somatostatin in H9c2 cells.
Somvanshi RK; Qiu X; Kumar U
Int J Cardiol; 2013 Aug; 167(3):1012-22. PubMed ID: 22465343
[TBL] [Abstract][Full Text] [Related]
19. Desmodium gangeticum (Linn.) DC. exhibits antihypertrophic effect in isoproterenol-induced cardiomyoblasts via amelioration of oxidative stress and mitochondrial alterations.
Sankar V; Pangayarselvi B; Prathapan A; Raghu KG
J Cardiovasc Pharmacol; 2013 Jan; 61(1):23-34. PubMed ID: 23052030
[TBL] [Abstract][Full Text] [Related]
20. Treatment of the cardiac hypertrophic response and heart failure with ginseng, ginsenosides, and ginseng-related products.
Karmazyn M; Gan XT
Can J Physiol Pharmacol; 2017 Oct; 95(10):1170-1176. PubMed ID: 28505464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]